Status: Recruiting
Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma
The goal of this clinical trial is to explore the effectiveness and adverse reactions of doxepin solution spray for alleviation of stubborn breakthrough pain induced by swallowing in patients receiving radiotherapy for nasopharyngeal carcinoma.
Participants needed: 178
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: Jun 23, 2026Locations: 1
Eligibility criteria
Provide informed written consent. [+6]
Known allergy to doxepin, tricyclic antidepressants, or any known component of t... [+8]